The purpose of this proposal is to develop a validated physiological model of the cardio- renal axis for submission to the FDA Medical Device Development Tool pilot program. The model will be used to aid in the development and regulation of devices intended to treat hypertension. Examples include medical devices for renal nerve ablation, electrical stimulation of the carotid baroreceptor or creation of an A-V Fistula. Given that 12-15% of US patients with uncontrolled hypertension even with the use of 4 or more drugs at a price tag of $11-$17 billion, the importance of a tool that streamlines the time for design, testing, and regulation of a non- pharmacological device is clear. The multifactorial nature of hypertension complicates its treatment, and no device intervention is guaranteed to successfully treat each patient. Our physiological model is a powerful tool for understanding interpatient variability and confirming the correctness of a device's context of use. In Phase I, we will demonstrate a validated and documented renal model, using HumMod, our existing model of human physiology as the basis for the new model.
The aims of this study include: 1) the transfer of the model from a proprietary simulation environment into a more powerful, validated framework, 2) documentation of the model by linking a bibliographic database with a wiki, and 3) a validation suite to ensure that the model functions correctly. The model will be implemented in Modelica, a multi-domain modeling language for modeling of complex system. In Phase II, we will use the workflows developed in Phase I to create, document, and validate the cardiovascular part of the axis, including neural reflex arcs and the relevant endocrine systems.

Public Health Relevance

This proposal will fund the development, documentation, and validation of a mathematical model that will aid device manufacturers and the FDA to streamline the current regulatory process. This will reduce the cost and time associated with bringing new devices to market while adding another layer of protection for consumers.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43FD005669-01
Application #
9138442
Study Section
Special Emphasis Panel (ZRG1-DKUS-L (11)B)
Project Start
2016-09-15
Project End
2017-03-31
Budget Start
2016-09-15
Budget End
2017-03-31
Support Year
1
Fiscal Year
2016
Total Cost
$131,863
Indirect Cost
Name
Hc Simulation, LLC
Department
Type
DUNS #
078374917
City
Canton
State
MS
Country
United States
Zip Code
39046